Securities registration termination [Section 12(g)]



STYLE="font: 10pt Times New Roman, Times, Serif">
















UNITED STATES




SECURITIES AND EXCHANGE COMMISSION




Washington, D.C. 20549






FORM 15






CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF


THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER


SECTIONS 13 AND 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.





Commission File Number 001-38707






LogicBio Therapeutics, Inc.



(Exact name of registrant as specified in its charter)






65 Hayden Avenue,




2nd Floor


Lexington, MA 02421




(617) 245-0399



(Address, including zip code,
and telephone number, including area code, of registrant’s principal executive


offices)






Common Stock, par value $0.0001 per share



(Title of each class of securities covered by this
Form)






None



(Titles of all other classes of securities for
which a duty to file reports under section 13(a) or 15(d) remains)





Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:






























































Rule 12g-4(a)(1)



x








Rule 12g-4(a)(2)



¨








Rule 12h-3(b)(1)(i)



x








Rule 12h-3(b)(1)(ii)



¨








Rule 15d-6



¨








Rule 15d-22(b)



¨









Approximate number of holders of record as of
the certification or notice date: one (1).





























Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant, LogicBio Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.









































Date:



November 29, 2022





LogicBio Therapeutics




, INC.












By:



/s/ David E. White






Name:



David E. White






Title:



Treasurer














The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever LogicBio Therapeutics makes a similar move, sign up!

Auto Refresh

Feedback